Arrhythmias, Cardiac
Recent clinical, regulatory, research and industry developments relating to this disease.
Circadian rhythms in cardiovascular disease.
Cardiovascular Effects of Antiseizure Medications for Epilepsy.
From bits to bedside: entering the age of digital twins in cardiac electrophysiology.
Epilepsy and Cardiac Arrhythmias: A State-of-the-Art Review.
A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers.
Digital twins for cardiac electrophysiology: state of the art and future challenges.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 1 clinical trial expected to report results, the earliest in Q4 2026.
- Active recent publication activity.
Research HighlightsViewHide
- 2025-09-01Circadian rhythms in cardiovascular disease.Kelters IR · 2025
Clinical MilestonesViewHide
- 2026-04-29ClinicalThe Leadless AV Versus DDD Pacing Study: A Randomized Controlled Single-center Trial on Leadless Versus Conventional Cardiac Dual-chamber PacingResults expected Q4 2026
- 2025-09-01ResearchCircadian rhythms in cardiovascular disease.Kelters IR · 2025
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes8
- Arrhythmias, Cardiac14
- Pacemaker, Artificial4
- Cardiology3
- Cardiovascular Diseases3
- Death, Sudden, Cardiac3
- Defibrillators, Implantable3
- Electrophysiologic Techniques, Cardiac3
- Heart Failure3
Leading journals6
- European heart journal12
- Circulation5
- Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology5
- Herzschrittmachertherapie & Elektrophysiologie2
- The New England journal of medicine2
- Annual review of medicine1
Leading researchers8
- Charron P4
- Lambiase PD4
- Baumgartner H3
- Behr ER3
- Conte G3
- Corrado D3
- Elliott PM3
- Gorenek B3
Affiliations (unnormalised)6
- Johns Hopkins University3
- Mayo Clinic3
- University of Michigan3
- Baylor College of Medicine2
- Cardiocentro Ticino Institute2
- Cardiovascular Institute2
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Disease profile
A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.
Cardiac arrhythmias are disturbances of the normal rhythmic beating of the heart or myocardial contraction. They can be classified by abnormalities in heart rate, disorders of electrical impulse generation, or disorders of impulse conduction.
The grounding supports several etiologic categories rather than a single cause. Arrhythmias may be associated with inherited cardiovascular disease, including genetic arrhythmic disorders and genetic dilated cardiomyopathy, and they may also be chemically induced. In acute COVID-19 cardiovascular syndrome, ventricular arrhythmias can occur in the setting of myocardial injury, with suspected causes including myocarditis, microvascular injury, systemic cytokine-mediated injury, stress-related cardiomyopathy, or possible direct viral replication in cardiomyocytes and pericytes.
The literature describes arrhythmogenesis as arising from abnormalities in cardiac electrophysiology across scales from ion channels to the whole organ. Mechanistically, arrhythmias reflect disturbed impulse generation or conduction and can be influenced by changes in heart rate, hemodynamics, stroke volume, exercise, and consensus-related electrophysiologic behavior. In some settings, such as acute COVID-19 cardiovascular syndrome, arrhythmias accompany cardiomyopathy and hemodynamic instability.
Inherited cardiovascular disease is a risk context for arrhythmic disorders, and genetic dilated cardiomyopathy is specifically linked with increased risk of arrhythmias and sudden cardiac death. The grounding also supports fetal and neonatal periods as vulnerable settings because immature myocardium can make bradyarrhythmias and tachyarrhythmias more hemodynamically significant. Acute COVID-19 hospitalization is another context in which ventricular arrhythmias have been reported.
Management is described at the modality and drug-class level rather than as a single uniform regimen. The grounding supports cardiac pacing and lead devices for conduction diseases, pharmacological antiarrhythmic treatment in fetal and neonatal arrhythmias, and broader electrophysiology-based management informed by diagnosis, classification, and genetic testing in inherited cardiovascular disease. In acute COVID-19 cardiovascular syndrome, management is framed around supportive and cardiovascular care for arrhythmias and hemodynamic instability.
AI-generated summary grounded in MeSH and 6 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.
Reference
Authoritative identity, definition & identifiers.
Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.